Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00779051 · ClinicalTrials.gov registry record · NA

Bioequivalence Study of Zolpidem 10mg Tablets Under Fasting Conditions

A NA study of Healthy, sponsored by Ranbaxy Laboratories Limited.

Completed
Registry status
NA
Development phase
36
Enrollment target
1
Study location

NCT00779051: Completed NA study of Healthy, sponsored by Ranbaxy Laboratories Limited.

NCT00779051 is a NA study of Healthy that has completed, run by Ranbaxy Laboratories Limited. The registered enrollment target is 36 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00779051, a NA study of Healthy, has completed, sponsored by Ranbaxy Laboratories Limited.

COMPLETED
Registry status
NA
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

The study compared the relative bioavailability (rate and extent of absorption) of 10 mg Zolpidem tablets by Ohm Laboratories Inc. with that of 10 mg Ambien® tablets distributed by Sanofi-Synthelabo, Inc. following single oral dose (1x10 mg tablet) in healthy adult volunteers administered under fasting condition

Conditions Studied

Healthy

Interventions

  • DRUG Zolpidem 10mg tablets

Study Locations (1)

North Dakota

  • PRACS Institute Ltd. - Fargo

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2005-08
Est. Completion 2005-10
Phase NA

Sponsor

Ranbaxy Laboratories Limited

44 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00779051

The ClinicalTrials.gov registry entry for NCT00779051 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower). The listed sponsor is Ranbaxy Laboratories Limited, which has 44 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Zolpidem 10mg tablets is the first listed.

NCT00779051 reports 1 study location spanning 1 distinct geographic area - top geographies include North Dakota.

Frequently Asked Questions

What is clinical trial NCT00779051 about?

NCT00779051 is a clinical study titled "Bioequivalence Study of Zolpidem 10mg Tablets Under Fasting Conditions". The study compared the relative bioavailability (rate and extent of absorption) of 10 mg Zolpidem tablets by Ohm Laboratories Inc. with that of 10 mg Ambien® tablets distributed by Sanofi-Synthelabo, Inc. following single oral dose (1x10 mg tablet) in healthy adult volunteers administered under fast...

What is the current status of trial NCT00779051?

This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2005-08. Estimated completion is 2005-10.

What conditions does trial NCT00779051 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT00779051?

The interventions under investigation include: Zolpidem 10mg tablets (DRUG).

Who is sponsoring clinical trial NCT00779051?

This trial is sponsored by Ranbaxy Laboratories Limited, which has 44 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00779051 being conducted?

This trial has 1 study location across North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

North Dakota

All trials with a study site in North Dakota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.